Toxicity Testing of Polymer Materials for Dialysis Equipment: Reconsidering In Vivo Testing

Abstract

The rationale for preclinical testing of plastic materials for medical devices is the protection of patients from leachable toxic substances. A controversial and costly part of this testing is the use of animal in vivo procedures. The objective of the present study was to analyse the importance of in vivo tests in relation to the decision to approve or not to approve materials for use. A total of 1044 plastic materials were analysed by employing chemical, in vitro and in vivo tests: 5708 in vivo tests were performed. In only one out of 2650 systemic injection tests on mice did a material fail. As that material also failed in chemical tests, the systemic injection test had no influence on the decision not to approve the material. Intradermal irritation (2644 tests), implantation (398 tests) and sensitivity (11 tests) procedures on rabbits and guinea-pigs were the other in vivo tests. However, in all except three cases, the same decision on whether or not to use a material would have been reached without any of these in vivo tests. Thus, little security appears to be gained from the in vivo tests, and abandoning them would save resources, probably without any additional risk.

Keywords

polymers materials medical devices dialysis toxicity in vivo

Get full access to this article

View all access options for this article.

References

USP (1990). United States Pharmacopeia XXII. Rockville, MD, USA: USP Convention Inc.

ISO (1993). Biological Testing of Medical and Dental Materiaals and Devices (ISO 10993). Geneva, Switzerland: International Standardization Organization.

Wilsnack

R.E.

(1976). Quantitative cell culture biocompatibility testing of medical devices and correlation to animal tests. Biomaterials, Medical Devices and Artificial Organs 4, 235–261.

Wilsnack

R.E.

, Meyer

F.J.

, & Smith

J.G.

(1973). Human cell culture toxicity testing of medical devices and correlation to animal tests. Biomaterials, Medical Devices and Artificial Organs 1, 543–562.

Autian

(1973). The new field of plastics toxicology: methods and results. In Critical Reviews in Toxicology. 40 pp. Cleveland, OH, USA: CRC Press.

Autian

(1977). Toxicological evaluation of bio-materials: primary acute toxicity program. Artificial Organs 1, 53–60.

Williams

D.F.

(1987). Progress in Biomedical Engineering, Vol. 4, Definitions in Biomaterials. 72 pp. Amsterdam, The Netherlands: Elsevier.

Kjellstrand

(1988). Giving life — giving death: ethical problems of high-technology medicine. Acta Medica Scandinavica, Suppl. 725, 1–88.

Nosé

(1993). Why do we kill so many patients on hemodialysis in the US? Artificial Organs 17, 893–894.

10.

Kjellstrand

, Liljehorn

, & Rydhög

(1994). Toxicity testing of polymer materials for dialysis equipment: is there any need for in vivo testing? Cell Biology and Toxicology 10, 137–142.

11.

DIN (1989). DIN-taschenbuch; 227. Medizinische Einmalartikel, Medicalprodukte; normen und weitere Unterlgen. Berlin, Germany: Oskar Zach GmbH & Co.

12.

FARM. ITALIANA (1988). Farmacopea ufficiale della republica italiana. Instituto poliografico dello stato PV. Rome, Italy: Ministro della Santifa.

13.

EUROP. PHARM (1993). European Pharmacopoeia, 2nd edn, 17th fasicule. Sainte-Ruffine, France: Maisonneuve.

14.

Borenfreund

, & Puerner

J.A.

(1985). Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicology Letters 24, 119–124.

15.

Kjellstrand

P.T.

, & Boberg

(1991). Testing of polymer materials: what methods should be used? ATLA 19, 222–225.

16.

Kjellstrand

P.T.

, & Boberg

(1991). Toxicity testing of polymer materials for use in hemodialysis. Toxicology in Vitro 5, 443–448.

17.

Wallin

R.F.

(1988). Current problems in device evaluation: some solutions. Journal of the American College of Toxicology 7, 491–497.

18.

Ekwall

, Bondesson

, Castell

J.V.

, Gómez-Lechón

M.J.

, Hellberg

, Högberg

, Jover

, Ponsoda

, Romert

, Stenberg

, & Walum

(1989). Cytotoxicity evaluation of the first ten MEIC chemicals: acute lethal toxicity in man predicted by cytotoxicity in five cellular assays and by oral LD50 tests in rodents. ATLA 17, 83–100.